145 related articles for article (PubMed ID: 19398593)
1. Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer.
Clark PM
J Clin Pathol; 2009 May; 62(5):402-6. PubMed ID: 19398593
[TBL] [Abstract][Full Text] [Related]
2. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
3. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
Whitley RJ; Ain KB
Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
[TBL] [Abstract][Full Text] [Related]
4. Can we interpret serum thyroglobulin results?
Clark P; Franklyn J
Ann Clin Biochem; 2012 Jul; 49(Pt 4):313-22. PubMed ID: 22589360
[TBL] [Abstract][Full Text] [Related]
5. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
Wong J; Lu Z; Doery J; Fuller P
Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
[TBL] [Abstract][Full Text] [Related]
6. Can we measure serum thyroglobulin?
Clark PM; Beckett G
Ann Clin Biochem; 2002 May; 39(Pt 3):196-202. PubMed ID: 12038593
[TBL] [Abstract][Full Text] [Related]
7. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Iervasi A; Iervasi G; Carpi A; Zucchelli GC
Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
[TBL] [Abstract][Full Text] [Related]
9. False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays.
Massart C; Corcuff JB; Bordenave L
Clin Chim Acta; 2008 Feb; 388(1-2):211-3. PubMed ID: 17963702
[No Abstract] [Full Text] [Related]
10. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
Barbosa GF; Milas M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
[TBL] [Abstract][Full Text] [Related]
11. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid.
Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Kameko F; Tajiri J; Kato R
Clin Chim Acta; 2007 Apr; 379(1-2):101-4. PubMed ID: 17270168
[TBL] [Abstract][Full Text] [Related]
13. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
14. Concordance between thyroglobulin antibody assays.
Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring.
Krahn J; Dembinski T
Clin Biochem; 2009 Mar; 42(4-5):416-9. PubMed ID: 19154731
[TBL] [Abstract][Full Text] [Related]
16. Empirically treating high serum thyroglobulin levels.
Mazzaferri EL
J Nucl Med; 2005 Jul; 46(7):1079-88. PubMed ID: 16000275
[No Abstract] [Full Text] [Related]
17. [Cellular tumor markers in thyroid cancer].
Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers for thyroid malignant disease].
Tamura K
Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
[No Abstract] [Full Text] [Related]
19. [Thyroglobulin mRNA detection in the follow-up of thyroid carcinomas].
Peuchant O; Corcuff JB; Georges A; Bordenave L
Ann Biol Clin (Paris); 2005; 63(5):503-6. PubMed ID: 16230285
[TBL] [Abstract][Full Text] [Related]
20. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
